Company Filing History:
2 out of 124 
2 out of 29 
1 out of 6 Years Active: 2017-2020
Title: Antoine Blancher: Innovator in Immunology
Introduction
Antoine Blancher is a notable inventor based in Toulouse, France. He has made significant contributions to the field of immunology, particularly in the development of monoclonal chimeric immunoglobulins. With a total of 2 patents, his work has the potential to impact medical diagnostics and treatments.
Latest Patents
Antoine Blancher's latest patents include innovative methods and kits for determining the quantity of anti-HLA antibodies in liquid mediums. One patent describes an anti-HLA monoclonal chimeric immunoglobulin, which features human heavy and light chains. This invention is particularly focused on the constant parts of the heavy chains, which can be selected from IgA, IgG, or IgM, and the light chains, which can be kappa or lambda. Another patent outlines a process for standardizing the screening and quantification of anti-HLA antibodies, enhancing the reliability of immunological assessments.
Career Highlights
Throughout his career, Antoine Blancher has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Toulouse and Université Paul Sabatier Toulouse III. His experience in these organizations has allowed him to collaborate on various research projects, furthering his expertise in immunology.
Collaborations
Antoine has collaborated with notable colleagues, including Nicolas Congy and Jean-Gerard Tiraby. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Antoine Blancher is a distinguished inventor whose work in immunology has led to significant advancements in the understanding and quantification of anti-HLA antibodies. His contributions are poised to enhance medical diagnostics and treatment methodologies.